A
ARCH VENTURE CORP
ARCH VENTURE CORP is an institution, managing $492.4M across 9 long positions as of Q3 2025 with 56% Healthcare concentration, with only 9 positions, and 22% allocation to RAPP.
- Portfolio Value
- $492.4M
- Positions
- 9
- Top Holding
- RAPP at 22.49%
- Last Reported
- Q3 2025
Top Holdings
Largest long holdings in ARCH VENTURE CORP's portfolio (100% of total portfolio)
GthenH
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Unknown Unknown | $110.7M | 22.49% | — | 8.09% 3.7M shares | |
Biotechnology Healthcare | $110.2M | 22.38% | — | 4.49% 4.5M shares | |
Unknown Unknown | $106.8M | 21.70% | — | 9.40% 4.1M shares | |
Biotechnology Healthcare | $73.8M | 14.98% | — | 9.30% 12.9M shares | |
Biotechnology Healthcare | $44.8M | 9.10% | +$15.2M Bought | 14.36% 2.8M shares | |
Biotechnology Healthcare | $24.1M | 4.89% | — | 3.90% 11.1M shares | |
Biotechnology Healthcare | $21.2M | 4.30% | — | 3.52% 8.1M shares | |
Biotechnology Healthcare | $634.6K | 0.13% | — | 2.63% 320.5K shares | |
Biotechnology Healthcare | $114.0K | 0.02% | — | 1.86% 22.4K shares |
Changes
Portfolio activity, position movements, and quarter-over-quarter changes in ARCH VENTURE CORP's latest filing
GthenC
Market Value
Q/Q Change
Net Flows % of MV
Turnover Ratio
New Purchases
Added To
Sold Out Of
Reduced Holdings
Increased Positions
| Position | Shares Δ |
|---|---|
+51.54% |
Decreased Positions
| Position | Shares Δ |
|---|---|
Sold | |
Sold |
Analytics
Portfolio insights and performance metrics for ARCH VENTURE CORP
GthenA